Texas 2025 - 89th Regular

Texas House Bill HB3717

Filed
3/4/25  
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

Companion Bills

TX SB2308

Similar Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.

Previously Filed As

TX HB5230

Relating to health benefit plan coverage of prescription drugs for serious mental illnesses and opioid and substance use disorders.

TX HB3460

Relating to coverage for mental health conditions and substance use disorders under certain governmental health benefit plans.

TX HB1357

Relating to Medicaid reimbursement for certain medication-assisted treatments for opioid or substance use disorder.

TX HJR135

Proposing a constitutional amendment providing for the establishment of the Mental Health and Brain Research Institute of Texas and establishing the Mental Health and Brain Institute Research Fund for the purposes of scientific research of all forms of mental health and human brain disease and disorders.

TX HB755

Relating to prior authorization for prescription drug benefits related to the treatment of autoimmune diseases and certain blood disorders.

TX HB4505

Relating to health benefit plan coverage for treatment of autism spectrum disorders.

TX HB4687

Relating to the administration of funding for the coordination of mental health, substance use, and public health care services in this state.

TX HB3724

Relating to the maternal mental health peer support pilot program for perinatal mood and anxiety disorder.

TX HB1293

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX HB3566

Relating to statewide standards for the provision of and health benefit plan coverage of substance use and addiction treatment.

Similar Bills

CA AB423

Alcoholism or drug abuse recovery or treatment programs and facilities: disclosures.

CA AB319

Narcotic treatment: medication-assisted treatment: Drug Medi-Cal.

CA SB924

Workers’ compensation: utilization review.

CA AB2848

Workers’ compensation: medical treatment.

CA SB489

Workers’ compensation: change of physician.

CA AB395

Substance use treatment providers.

CA SB636

Workers’ compensation: utilization review.

CA AB772

Workers’ compensation: domestic terrorism.